Table 1.
Individual Disclosures for the NCCN Small Cell Lung Cancer Panel
| Panel Member | Clinical Research Support | Advisory Boards, Speakers Bureau, Expert Witness, or Consultant | Patent, Equity, or Royalty | Other | Date Completed |
|---|---|---|---|---|---|
| Wallace Akerley, MD | Genentech, Inc.; and OSI Pharmaceuticals, Inc. | Genentech, Inc. | None | None | 11/8/11 |
| Paul Bogner, MD | None | None | None | None | 1/31/12 |
| Hossein Borghaei, DO, MS | Genentech, Inc.; and Millennium Pharmaceuticals, Inc. | Amgen Inc.; and Genentech, Inc. | None | None | 7/2/12 |
| Laura QM Chow, MD | None | None | None | None | 3/26/12 |
| Robert J. Downey, MD | None | None | None | None | 3/22/12 |
| Leena Gandhi, MD, PhD | None | None | None | None | 12/17/11 |
| Apar Kishor P. Ganti, MD | Pfizer Inc. | None | None | None | 3/27/12 |
| Ramaswamy Govindan, MD | None | AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim GmbH; Bristol-Myers Squibb Company; Covidien AG; Genentech, Inc.; GlaxoSmithKline; and Pfizer Inc. | None | None | 3/28/12 |
| John C. Grecula, MD | Sci-Clone; and Teva/Cephalon | None | None | None | 4/18/2012 |
| James A. Hayman, MD, MBA | None | None | None | None | 2/16/12 |
| Rebecca Suk Heist, MD, MPH | None | None | None | None | 11/18/12 |
| Leora Horn, MD, MSc, FRCPC | Boehringer Ingelheim GmbH | Genentech, Inc.; and OSI Pharmaceuticals, Inc. | None | None | 8/16/12 |
| Thierry M. Jahan, MD | Eli Lilly and Company; Genentech, Inc.; ImClone Systems Incorporated; Morphotek Inc.; Novartis Pharmaceuticals Corporation; and Merrimack pharmaceuticals | None | None | None | 3/27/12 |
| Gregory P. Kalemkerian, MD | Eli Lilly and Company | None | None | None | 10/10/12 |
| Marianna Koczywas, MD | None | None | None | None | 3/28/12 |
| Billy W. Loo Jr, MD, PhD | None | None | None | Siemens Medical Solutions Diagnostics; and Varian Medical Systems, Inc. | 1/31/12 |
| Robert E. Merritt, MD | None | None | None | None | 10/11/12 |
| Cesar A. Moran, MD | None | None | None | None | 3/27/12 |
| Harvey B. Niell, MD | None | None | None | None | 4/7/12 |
| Janis O’Malley, MD | None | None | None | None | 4/13/11 |
| Jyoti D. Patel, MD | Eli Lilly and Company | Genentech, Inc. | None | None | 3/26/12 |
| Neal Ready, MD, PhD | Pfizer Inc. | None | None | None | 3/27/12 |
| Charles M. Rudin, MD, PhD | None | Aveo Pharmaceuticals; and Oncothyreon | None | None | 12/7/11 |
| Charles C. Williams Jr, MD | None | None | None | None | 2/24/12 |
The NCCN guidelines staff have no conflicts to disclose.